We previously reported on the potential clinical utility of serum cytokines in this cohort [20] and demonstrated that IL-8 and CCL2 in combination were prognostic for all-cause mortality and that IL-17A alone had better power to identify patients who developed persistent bacteremia than available clinical and lab metrics. This evidence concerns the gene CCL2 and bacterial infectious disease with sepsis.